Business
Bio Spectrum
Nanoparticles For Treating Eye Infections
Scientists at the Hyderabad-based CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB) have developed a novel way to treat fungal keratitis.
1 min |
July 2017
Bio Spectrum
Global Pharma Continues To See Potential In Investing In R&D In India
Innovative biopharmaceutical companies around the world continue to strive to accelerate the pace of innovation and deliver effective medicines to patients quickly and efficiently. By investing more time, energy, and resources in collaboration across the R&D ecosystem and leveraging more sophisticated research and manufacturing tools, these companies in India continue to invest in R&D and advance the science forward.
6 min |
July 2017
Bio Spectrum
Competition Is Getting Fierce Among The 'Health Startups' In India
Medical care is just a click away but this has also blown a trumpet of online combat between these startups. Currently, it may look like a wide field to play in but in the coming years, there will be more players joining these online battle and then it will become a cut throat competition
9 min |
July 2017
Bio Spectrum
GST To Have Constructive Effect On The Pharma And Healthcare Sectors
Though healthcare and pharma sectors hailed the announcement of GST rates, by saying that GST will encourage local manufacturing sector to step into producing products that will be more affordable for the local consumers. But with introduction of GST ayurvedic medicines will be taxed at 12 per cent from the current tax rate of 7 per cent, which has disappointed the Ayurvedic medicines industry badly.
5 min |
July 2017
Bio Spectrum
There Is Need To Increase Awareness About Clinical Research That Has Done Good For Patients
There Is Need To Increase Awareness About Clinical Research That Has Done Good For Patients
4 min |
July 2017
Bio Spectrum
The New Challenges Demand That We Make Innovative Strategies: J P Nadda
The New Challenges Demand That We Make Innovative Strategies: J P Nadda
2 min |
July 2017
Bio Spectrum
Natco Pharma Plans API Expansion With More Investment
Hyderabad-based Natco Pharma is planning to expand its Active Pharmaceutical Ingredient (API) and intermediates manufacturing facility in Tamil Nadu. The company is looking at investing in its existing facility, in Thiruvallur District.
1 min |
November 2017
Bio Spectrum
IP In Start-Up Ecosystem
In this age of innovation and technology, Intellectual Property (IP) is an essential element for an organization to sustain and flourish over long periods of time. This is particularly applicable for organizations which rely heavily on R&D to develop technology based solutions for existing problems, and the biotech startup community is no different.
4 min |
November 2017
Bio Spectrum
India To Bounce Back As Clinical Research Hub
India was considered as an all-time favoured destination for clinical trials. Most of the outsourced studies are phase III studies where India has a diverse pool of patients. After 2010 there was major setback in the CRO industry in India. Drug Controller General of India (DCGI) approvals were delayed and multinational sponsors stepped back outsourcing studies to India. But slowly post 2016 DCGI has been generous enough in proving approvals and online application system has brought a lot of difference. Indian Clinical Trial market and clinical trial services is expected to grow significantly along with trends.
8 min |
October 2017
Bio Spectrum
“Private Sector, Government Need To Work Together To Make Healthcare Accessible In Rural India”
For the first time National Heath Policy is talking about the preventive healthcare and wellness. From the statement point of view, it is really a commendable thing but now it has to be translated on to the ground. Harish Pillai COO, Indus Health Plus in an interaction with BioSpectrum India talks about why preventive healthcare is the need of the hour and how it can be successful.
5 min |
November 2017
Bio Spectrum
Make In India' - A Major Boon To Medical Technology Industry
Having a solid expertise in research and development, Trivitron manufactures and distributes exceptional medical technology products to 165 countries for the last 20 years. Today, Trivitron Healthcare, through successful inorganic synergies with local and global firms, has a revenue turnover of Rs 750 crore. BioSpectrum India spoke to Dr GSK Velu, Chairman & Managing Director, Trivitron Healthcare Group of Companies to about the status of medical technology market in India and competition coming from Chinese medical devices.Excerpts of the interview
4 min |
November 2017
Bio Spectrum
Association Of Indian Medical Device Industry (AIMED) Recommendations
Association Of Indian Medical Device Industry (AIMED) Recommendations
2 min |
November 2017
Bio Spectrum
Medical Devices Rules, 2017 Opens Up Enormous Opportunities
The new Medical Devices Rules, 2017 seek to remove regulatory bottlenecks to make in India, facilitate ease of doing business while ensuring availability of better medical devices for patient care and safety. The rules will also regulate a much larger set of medical devices under a framework customized for medical devices. The stakeholders are hoping that the system will be industry friendly and will indeed create an ecosystem that will enable to boost medical technology innovation and manufacturing in the country.
10 min |
November 2017
Bio Spectrum
Thermo Fisher Scientific India Conducts Genetic Solutions World Tour
As part of the Genetics Solutions World Tour, Thermo Fisher India recently organized seminars in Delhi & Bengaluru to showcase our market leadership and establish new opportunities for Sanger sequencing, Next Generation Sequencing (NGS) and Microarray.
3 min |
September 2017
Bio Spectrum
Special News
Kiran Medical Systems Bags Healthcare Award
1 min |
September 2017
Bio Spectrum
Supplier News
IISc Researchers Propose A More Effective Treatment For Tuberculosis
1 min |
September 2017
Bio Spectrum
The Nano Approach Of Medicines
Increase in adoption of novel nanomedicines products drives the market growth in India. Moreover, increase in the number of players and high adoption of innovative technologies further fuel the market growth. In addition, robust government initiative toward improvement of healthcare facilities through insurance schemes is anticipated to provide lucrative growth opportunities in the country. The nanomedicines market in India is expected to grow at the highest CAGR of 13.4% from 2016 to 2023.
5 min |
February 2018 ,Vol 16 Issue 05
Bio Spectrum
High Growth Health Insurance Market Still Remains Underpenetrated
India’s healthcare industry is one of the fastest growing sectors and in the coming 10 years it is expected to reach $275 billion. Indian healthcare sector is much diversified and is full of opportunities in every segment which includes providers, payers and medical technology. With the increase in the competition, businesses are looking to explore for the latest dynamics and trends which will have positive impact on their business.
6 min |
February 2018 ,Vol 16 Issue 05
Bio Spectrum
India Gets Its First Oncology Tutorial Series
The Union Health Ministry has launched a digital Online Oncology Tutorial Series, which is part of a national programme that will be rolled out across the country in collaboration with state governments.
1 min |
February 2018 ,Vol 16 Issue 05
Bio Spectrum
“Data Sharing, Post Study Access To Trial Medication Are Emerging Frontiers”
“Data Sharing and Post study access to trial medication for study subjects are the two emerging frontiers in clinical research space,” said Dr Saral Thangam, CEO & Managing Director, Norwich Clinical Services.
2 min |
October 2017
Bio Spectrum
Biotechnology - Where Is It Heading?
On one hand, the biotechnology industry is starved of skilled talent pool. On the other hand, there are several universities and colleges, producing number of unemployable graduates. While some of them are struggling due to lack of students. So serious thinking needs to be done urgently to overcome this problem.
2 min |
October 2017
Bio Spectrum
Pharma Exporters To US Under Pressure
Recent USFDA hike of fee for processing ANDA will certainly going to put immense pressure on the Indian pharma industry, resulting eviction of many small players from this pharma export business.
5 min |
October 2017
Bio Spectrum
“We Have Streamlined The Whole Process Of Reviewing And Approval”
Indian Council of Medical Research (ICMR) signed an agreement recently with other global agencies to develop and implement policies within the next 12 months that require all trials they fund, co-fund, sponsor or support to be registered in a publicly available registry.
3 min |